Evidence map›Paper›PMID 11405979›Full record

SynthesisThe Cochrane database of systematic reviews2001

House dust mite control measures for asthma.

P C Gøtzsche, H K Johansen, C Hammarquist, M L Burr

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Antigen-induced mast cell expansion and bronchoconstriction in a mouse model of asthma.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  3. House dust mite control measures in the treatment of asthma.Therapeutics and clinical risk management · 2006
    Article
  4. Should UK allergy services focus on primary care?BMJ (Clinical research ed.) · 2006
    Article
  5. Skin test reactivity to indoor allergens correlates with asthma severity in jeddah, saudi arabia.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2006
    Article
  6. [Atopic eczema. Spectrum of provocation factors and possibilities for their effective reduction and elimination].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2003
    Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

P C GøtzscheThe Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, Copenhagen Ø, Denmark, 2100. p.c.gotzsche@cochrane.dk
H K Johansen
C Hammarquist
M L Burr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe major allergen in house dust comes from mites. Chemical, physical and combined methods of reducing mite allergen levels are intended to reduce asthma symptoms in people who are sensitive to house dust mites.

objectivesThe objective of this review was to assess the effects of reducing exposure to house dust mite antigens in the homes of mite-sensitive asthmatics. SEARCH STRATEGY: We searched the Cochrane Airways Group trials register, checked reference lists of articles and hand-searched Respiration (1980 to 1996) and Clinical and Experimental Allergy (1980 to 1996). The Cochrane Library is searched every three months. SELECTION CRITERIA: Randomised trials of mite control measures vs placebo or no treatment in asthmatic people known to be sensitive to house dust mites. DATA COLLECTION AND ANALYSIS: Two reviewers applied the trial inclusion criteria, assessed their quality and extracted the data independently. Study authors were contacted to clarify information. MAIN

resultsTwenty-nine trials (939 patients in the analyses) were included, with two trials awaiting assessment. There was little difference in improvement of asthma between patients in experimental groups compared to control groups (relative risk 1.04, 95% confidence interval (95%CI) 0.83 to 1.31). Asthma symptom scores were also similar for the experimental and control groups (standardised mean difference (SMD) -0.07, 95% CI -0.35 to 0.22), however there was significant heterogeneity between studies p=0.015. This appears to have been due, in part, to the parallel group studies of physical treatments. These three studies (107 patients) showed a significant reduction in symptoms; SMD -0.44 (95% CI -0.83, -0.06) with no heterogeneity between the trials. No significant difference was noted for medication usage (SMD -0.14, 95%CI -0.43 to 0.15). Peak flow in the morning showed no significant difference between the experimental and the control groups (SMD 0.04, 95%CI -0.13 to 0.21). REVIEWER'S

conclusionsCurrent chemical methods aimed at reducing exposure to house dust mite allergens seem to be ineffective and cannot be recommended as prophylaxis for mite sensitive asthmatics. Physical reduction methods may reduce asthma symptoms, but results of larger and more rigorous studies are required before any recommendations can be made concerning this approach.

Indexed as

Environment, ControlledInsecticidesAllergensAnimalsAsthmaDustEnvironmental ExposureHumansMitesRandomized Controlled Trials as TopicAllergensDustInsecticides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.